{"disease":{"id":"cutaneous-neurofibroma","name":"cutaneous neurofibroma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07327164","title":"Precision Medicine for Neurocutaneous Syndromes in Western China","phase":"","overall_status":"COMPLETED","enrollment_count":1200,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT05581511","title":"Natural History Study of Cutaneous Neurofibromas in People With NF1","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT05005845","title":"NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":199,"lead_sponsor_name":"NFlection Therapeutics, Inc.","has_results":true},{"nct_id":"NCT04435665","title":"NFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"NFlection Therapeutics, Inc.","has_results":true},{"nct_id":"NCT04730583","title":"Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT06159166","title":"Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT05119582","title":"HIFU Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1: Safety and Efficacy","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Joergen Serup","has_results":true},{"nct_id":"NCT05438290","title":"DPCP to Treat Cutaneous Neurofibromas Associated With NF1","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Nicholas Gulati","has_results":false},{"nct_id":"NCT02839720","title":"Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT03090971","title":"Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":7,"lead_sponsor_name":"Fundação Educacional Serra dos Órgãos","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}